In conclusion, the STEP TEENS trial demonstrated the efficacy of once-weekly semaglutide 2.4 mg plus lifestyle intervention in reducing BMI when compared to lifestyle intervention only
Wegovy is currently licensed for long-term use
While originally developed for blood sugar management, GLP-1 and GIP therapies are now commonly used under medical supervision to support metabolic health, weight management, and body composition in individuals who meet appropriate criteria
Other reviews report inconsistent results across intensity zones, populations, and outcomes
Yes Thailand has doctor-supervised access to GLP-1 medications, but only via prescription and assessment
That made it pretty useless as a drug on its owntoo fleeting to have a real therapeutic impact